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A U T H O R

Edward Matin Kobraei

I

am a senior majoring in biology.  
The work I present here is part
of an ongoing project as a 20072008 Beckman Scholar.   Throughout
my undergraduate studies, I have
developed a particular interest in
the human central nervous system.  
My work in Dr. Snow’s lab has
allowed me to explore the nature of
failed regeneration following spinal
cord injury.   This work has been
instrumental in guiding my future course of study, as I
will be attending medical school in the fall and ultimately
intend on entering the field of neurology.  
I have also been especially fortunate to have a
mentor such as Dr. Diane Snow in the department of
Anatomy and Neurobiology.  Ever since I began working
with her in January, 2007, she has been incredibly
supportive and concerned with the work I do in the
lab.   She has given me my own project to work on
and has invited me to several national meetings.   I
express my deepest gratitude for the time, energy, and
encouragement she has given me for the entire duration
that I have known her.  
In addition to undergraduate research, I am also
active in a number of other activities.  During the 20072008 academic year, I was a student instructor for both
the BIO 190 and CHE 197 workshop courses at UK.  I
was also a returning student ambassador for the College
of Arts and Sciences at UK.

Behavioral and
Morphological Parameters
of Neurons Predict the
Inhibitory Potential of
CSPG Motifs:
A Novel Technique.
Abstract
Our lab aims to systematically identify the structural elements of
chondroitin sulfate proteoglycans (CSPGs) that inhibit regeneration
following spinal cord injury (SCI).  CSPGs are extracellular matrix
molecules produced by astrocytes of glial scar tissue following SCI.  
Central to this project is the use of CSPGs referred to as “Designer
PGs,” which contain engineered modifications in the GAG chains and/
or the protein core of the neural CSPG aggrecan.  Using established
bioassays in vitro, we qualitatively and quantitatively measure growth
cone behaviors and morphology as they interact with Designer PG
molecules.  These measurements are then translated into a composite
inhibitory quotient (IQ) score that reflects the inhibitory strength of
the particular Designer PG.  Scoring is completed through application of our comprehensive inhibitory quotient (IQ) system scoring
criteria.  The utility of the IQ system is that it allows us to evaluate
and directly compare all experimental CSPGs.  IQ scores can then
be mapped back to the structure of the experimental CSPG, allowing
us to pinpoint the inhibitory domains of CSPGs.  The long term goal
of this methodology is to develop clinical therapies that selectively
target the most inhibitory CSPG domains while leaving unaltered the
beneficial aspects of the glial scar, thereby supporting regeneration
and recovery of function following SCI.

Faculty Mentor: Dr. Diane Snow
Eddie Kobraei is an exceptional student who has done exceptional research as a Beckman Scholar (2007-2008).  His project in my lab
entitled, “Quantification of Neuronal Growth Cone Responses to Specific Chondroitin Sulfate Proteoglycan Motifs” has been extremely
challenging and represents a mature endeavor, even for more advanced students.  Eddie has been diligent from day one and has done
an amazing job, accumulating data, critically analyzing the data, and
presenting the results at a variety of meetings both local and national.  
From observing Eddie as he progresses through this study, it is clear
that he is very intelligent, highly-motivated, mature beyond his years,
and capable.  I have been very impressed with Eddie’s work ethic and
drive as he has analyzed neuronal growth cone behavior in response to
inhibitory proteoglycans. This project requires great attention to detail,
and extreme accuracy, as well as long hours of analysis.  Eddie has
given 100% on all accounts.  The article he is currently submitting to
Kaleidoscope is written superbly and is a thorough representation
of the project he has done. The depth and breadth of inquiry he
describes demonstrate his integral involvement in the project
and his abundant academic talents.   
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Introduction

Substratum Preparation

Spinal cord injury (SCI) is a debilitating condition currently afflicting approximately 255,000 people in the U.S. alone (NSCISC, 2008). This condition presents formidable challenges to successful post-trauma recovery
of function and often results in permanent central nervous system (CNS)
damage. A hallmark of regeneration failure following SCI is the up-regulation of inhibitory chondroitin sulfate proteoglycans (CSPGs) by astrocytes
of the glial scar (Fitch and Silver, 2008). One member of the CSPG family
that is up-regulated is aggrecan (Figure 1), which can serve as a model for
this family of aggregating proteoglycans. Although studies in vitro and in
vivo have localized the inhibition largely to the glycosaminoglycan (GAG;
sugar) portion of CSPGs (Snow et al., 1990), the specific parts of the GAG
chains or possible protein domains responsible for inhibition remain unidentified. Further, the effects of specific CSPG motifs on neuronal growth
cone behaviors have yet to be systematically quantified.
In the present study, we are identifying the precise structural microheterogeneities of CSPGs that make them inhibitory to neuronal growth cones,
using a novel technique involving: 1) “Designer PGs” and, 2) an “Inhibitory
Quotient (IQ)” analysis system. Designer PGs are discrete aggrecan mutants
that are produced with altered properties (elimination of specific sites for
glycosylation, alterations in sugar chain length, or number, composition, or
deletion of individual domains) to identify modifications affecting neurite
outgrowth. With the IQ system, a wide variety of behavioral and morphological parameters of neuronal growth cones are qualitatively and quantitatively
evaluated from time-lapse images as growth cones contact and respond to
Designer PGs. The IQ system is then used to translate these responses into
composite IQ scores for each Designer PG, which is an indication of the
degree of inhibitory strength of each PG (see Methods).
The results of this on-going study are serving to identify the structural
moieties responsible for the inhibitory action of CSPGs, and are providing insight into the ways in which growth cones respond to proteoglycan
molecules. The long-term goal of these studies is to develop strategies to
manipulate the most inhibitory domains of CSPGs to render them noninhibitory.  In this way, glial scars will remain intact to facilitate the normal
healing and repair processes, but CSPGs will allow regeneration, ultimately
promoting recovery of function in patients with SCI.

Figure 1: Native Aggrecan.

Glass coverslips were mounted over holes in the bottom
of 50 mm polystyrene Petri dishes.  A 0.1 mg/ml poly
L-lysine solution was applied to the coverslip to provide
an adhesive surface for the binding of other molecules
of interest.  The glass coverslips were then washed two
times with PBS and allowed to dry. Purified CSPGs were
applied using cellulose strips (Whatman filter paper) in
a pattern onto the poly L-lysine background (Modification of Snow et al., 2002).   Laminin (25 μg/ml) was
then applied to the entire coverslip, and incubated at
room temperature for 1 hr.  The substratum was then
washed to remove unbound laminin or CSPGs from
the substratum. The result was a patterned substratum
consisting of alternating stripes of adsorbed CSPGs and
laminin.  (Figure 2)

Figure 2: Stripe Bioassay

Growth Cone Parameter Analysis
Growth Cone Measurements

A Zeiss Axiovison image analysis system was used to
record time-lapse videos of individual DRG neurons as
they approached and contacted CSPG stripes.  The videos
were then reviewed frame by frame and used to record
measurements of numerous outgrowth parameters, with
particular emphasis on the behavior of the leading “exploratory” component of the DRG neurons, called the
growth cone (GC) (Figure 3 and Table 1).

Methods:
Bioassays

Sensory Neuron (DRG) Dissection
Embryonic dorsal root ganglia (DRG) neurons were dissected on ice according to AAALAC regulations governing animal welfare and transferred
to culture dishes containing 500 μl of Dulbecco’s Modified Eagle Media
(DMEM) with F12 HEPES in a 1:1 ratio. The DRG were cut into small explants
and plated on the substratum described below. The substratum plates were
incubated at 37°C for ~6 hr.

Figure 3: Growth Cone Measurement Analysis
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Table 1: Partial List of Growth Cone Parameters
Measured
GROWTH CONE MORPHOLOGY		

GROWTH CONE BEHAVIOR

Growth Cone Area

Growth on PG Stripe

Growth Cone Length

Growth Rate

Growth Cone Width

Growth Cone Acceleration

Number of Filopodia

Growth Cone Retraction

Max Filopodial Length

Growth Cone Turning

Total Length of Filopodia

Growth Cone Branching

Figure 4: Four Zones of Outgrowth on Patterned
Substratum in Assays in vitro

Table 2: IQ System Scoring Criteria
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Each of these GC parameters was measured in four different zones of neuronal outgrowth relative to the PGadsorbed stripe.  Note that Zone 1 neuronal responses
were taken as the baseline values, as no contact with
the experimental CSPG is made throughout this zone.
(Figure 4)

Inhibitory Quotient (IQ) System

Quantitative Assessment of Inhibition
The IQ system is a novel method by which to translate
measurements of growth cone responses to Designer
PGs into a quantitative, composite IQ score for each PG,
to reflect the degree of inhibitory strength of each PG
tested.  To set the criteria, two PG standards were used
that represent the extremes of growth cone behavior
in response to this class of molecule: 1) bovine [adult]
articular cartilage aggrecan (Sigma #A1960), which is
highly decorated with GAG chains and induces complete
inhibition of growth cone elongation; and 2) recombinant aggrecan expressed in the cell line CHO-745, which
is deficient in xylosyl transferase, thus the CSPG is devoid of GAG chains, and is completely non-inhibitory
to growth cone elongation.  Growth cone responses to
these two molecules set the criteria for analysis of all
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subsequent Designer PGs, e.g., COS-7-derived aggrecan
(see Results).
Development of the criteria (Table 2) for growth
cone analysis required calculation of a single X and Y
value for each of the two control PGs for every parameter.  
X and Y values summarize all experiments for a given
PG (n=3) and represent changes in behavior compared
to growth on laminin alone (zone 1):

Comparison of behaviors in Zone 2 to Zone 1:
[ Avg. Z2/Z1 = X ] (n=3)
Comparison of behaviors in Zone 3 to Zone 1:
[ Avg. Z3/Z1 = Y ] (n=3)

5B

Figure 5(A-B): Growth Cone Width and Area are
Reliable Predictors of CSPG Inhibition.

Because the inhibitory trends for a given parameter were
reflected in the X and Y values for each standard PG, a
quantifiable basis for criteria development was established.  Individual criteria were developed separately for
zone 2 and zone 3 trends for each parameter and a point
value of 0-2 was given depending on the extent to which
the X and Y values reflected inhibitory responses (0 =
least inhibitory, 2 = most inhibitory).  The criteria for
each parameter are integrated into category scores and
then combined into a comprehensive scoring criterion
that yields a composite IQ score ranging from 0-30 (least
to most inhibitory).   Although the raw data become
compressed, the utility of the scoring criteria and computation of X and Y values is that they can be used to
assign a composite IQ score to any experimental CSPG.  
Further, raw data is still taken into consideration, as is
qualitative data for each growth cone’s response.

Results:

Growth Cone Behaviors Reflect the Degree of CSPGInduced Inhibition
(Figure 5A)  For the growth cone width parameter, both
the X values (p = 0.027, t test) and the Y values (p =
0.011, t test) are significantly different for the bovine
aggrecan positive control and the CHO 745 negative control.  Such differences were quantified and incorporated
into the IQ scoring criteria.  (Figure 5B)  Y values for both
the positive and negative CSPG controls reveal significant
differences (p = 0.039, t test) in growth cone area.

Composite IQ Scores Differ Between Designer
PGs

Figure 6: Composite IQ Scores for Three CSPGs.

The IQ system is sensitive in distinguishing the inhibitory
capacity of three CSPGs with very different properties.  
The “COS-7 Designer PG” is a mutant form of aggrecan
(see Methods).  Note that its inhibitory properties are
somewhat intermediate between those of bovine aggrecan and CHO-745 CSPGs. (Figure 6)

T h e U n i v e r sit y o f K e n tuck y J ou r n al o f U n de r g r aduate S c h ola r s h ip
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Discussion:
Two important conclusions immediately follow from
this work.  First, select behavioral and morphological
parameters of DRG neurons are reliable predictors of
CSPG-induced inhibition.   This finding was readily
shown by the statistically significant differences in
responses of neurons to the bovine aggrecan and CHO745 CSPG standards for the parameters, “growth cone
area” and “growth cone width.”  Significant differences
were also observed for a number of other growth cone
parameters, reinforcing the notion that such parameters
reflect the inhibitory capacity of CSPGs.  
Second, the differences we observed for growth
cone responses to various CSPGs can be quantified and
incorporated into a comprehensive scoring criterion.  
Because the two CSPG standards together comprise the
entire spectrum of inhibitory responses (complete inhibition to no inhibition), values calculated for the bovine
aggrecan established the criteria for maximum inhibition
and values for CHO-745 CSPG established criteria for
minimum inhibition.  Values intermediate to those observed for the two standard CSPGs were assigned scores
indicating intermediate inhibitory effects.  Extension of
this analysis to several other growth cone parameters
then facilitates calculation of category scores, which
are then combined to ultimately give the composite IQ
score.  The IQ system thus allows for the evaluation of
any experimental CSPG (“Designer PG”).
A third result of this study thus far that is quite intriguing and novel in the field is that a blinded statistical
analysis of the linear data for growth cone behaviors in
response to CPSGs showed that values related to growth
cone morphology significantly changed in the frame just
following single filopodial contact with the inhibitor.  For
many years, researchers have questioned whether there
is a cell surface receptor for CSPGs, with no resulting data
to date to support this theory.  That a cell can change its
morphology immediately following contact with a single
filopodium suggests that a receptor-mediated event is
not out of the question, and supports further research in
this regard.  However, an alternative explanation might
be effects of charge density, given the large degree of
sulfation of CPSGs, or regulation of calcium-mediated
events (Snow et al., 1992).  These possibilities remain
to be tested.
The IQ system analysis is not only consistent among
different PG samples, but is also consistent among different users.  This is true with respect to both growth cone
measurement analyses as well as composite IQ score
formulation.  As such, it can be applied repeatedly to
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derive IQ scores for different CSPGs, and can be adopted
for use on a more universal scale to test a wide variety of
molecular cues.  One NIH reviewer of this project stated
the methodology “may become the standard in the field.”  
The results thus far support this prediction.
Further application of the IQ system of scoring
with several Designer PG constructs will uncover the
structural basis of CSPG-based outgrowth inhibition.  
The importance of this work is underscored by the fact
that identification of these inhibitory domains should
ultimately permit clinical applications to reduce inhibition, promote axonal regeneration, and counteract the
utterly debilitating and presently irreversible nature of
spinal cord injuries, to facilitate functional recovery.    
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